 Home > Chemicals Industry > China Chemical > In 2021, the pharmaceutical equipment industry will present 4 major trends

In 2021, the pharmaceutical equipment industry will present 4 major trends

 Last Update: 2022-01-11
 Source: Internet
 Author: User

Tags

chemical elements table

chemical containers inc

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

[ Market analysis of chemical machinery equipment network ] The year of the rat is gone, and the year of the ox is here.
For the coming of the new year, all walks of life are full of expectations and full of enthusiasm.
At the same time, industry trends and challenges have also attracted attention from the industry.
Looking forward to 2021, the author, combined with the representative new actions of domestic pharmaceutical machinery companies, predicts that the domestic pharmaceutical equipment industry will show at least four major trends.

Chemical machinery and equipment network market analysis chemical machinery and equipment

Trend 1: Pay more attention to intellectual property protection

Strengthening the protection of intellectual property rights is an inherent requirement for stimulating innovation of pharmaceutical machinery companies, improving their competitiveness, and promoting the high-quality development of the pharmaceutical equipment industry.

In November 2020, my country’s "Opinions on Strengthening the Protection of Intellectual Property Rights" clearly stated that by 2022, infringement prone to frequent occurrences will be effectively curbed; by 2025, social satisfaction with intellectual property protection will reach and maintain a high level , The protection capacity is effectively improved, and the protection system is more perfect.
It is foreseeable that the promulgation of this document will force pharmaceutical machinery companies to pay more attention to the protection of intellectual property rights and promote the development of the domestic pharmaceutical equipment industry in a high-quality and innovative direction.

　　In fact, in recent years, with the improvement of the independent innovation capabilities of domestic pharmaceutical machinery companies, many companies are also actively deploying in terms of intellectual property protection.
For example, Xinma Pharmaceutical Machinery stated at the IPR implementation kick-off meeting held on December 25, 2020 that the company will strengthen scientific management through the establishment of an IP system, further enhance awareness, effectively promote IP protection capabilities, and enhance independence.
The awareness of innovation and the improvement of market competitiveness have pushed the company's intellectual property rights into a new stage of standardization, standardization and systematic management.

　　Trend 2: Speeding up market entry

　　As local pharmaceutical companies continue to increase R&D investment and continue to innovate and develop, local companies will accelerate their entry into the market.
For example, the industry is paying more attention to Romaco, a pharmaceutical equipment automation solution provider acquired by Chutian Technology.
With the help of cross-border mergers and acquisitions, Chutian Technology accelerates its development strategy and enhances market competitiveness and profitability.

　　At present, the concentration of domestic pharmaceutical machinery industry is still relatively low, mostly small and medium-sized enterprises.
While achieving the goal of becoming bigger and stronger through mergers and acquisitions, and speeding up market entry, it is also conducive to increasing market concentration.

　　Trend 3: Increasing differentiated competition

　　At present, competition in the domestic pharmaceutical machinery market is still very fierce, and the phenomenon of product homogeneity is serious.
It is the breakthrough point of major pharmaceutical machinery companies to seek differentiated competitive methods.

　　In September 2020, Canaan Technology announced that it intends to raise 450 million yuan to invest in five projects including the construction of an intelligent logistics system production center and the construction of a pharmaceutical liquid dispensing system production center.
The company said that the pharmaceutical liquid dispensing system production center construction project in this fundraising project is in a competitive field with high technical requirements.
The company will use its R&D strengths to improve the level of product intelligence and establish a differentiated competitive advantage.

　　No *Coincidentally, Tofflon announced in December 2020 that its subsidiary plans to invest 500 million yuan in the construction of a biopharmaceutical system equipment industrialization project, aiming to expand the production capacity of bioequipment and further enhance the company's overall bioengineering solution capabilities.

　　Trend 4: Accelerate the promotion of "intelligent manufacturing"

　　With the increase in consumer consumption and the intensification of aging, the demand for medicines will continue to expand.
It is estimated that my country's biopharmaceutical market will reach 464.
4 billion yuan in 2021, and the market size may exceed 500 billion yuan by 2025.
In the process of continuous development and growth of the upstream pharmaceutical industry, intelligent manufacturing will further help it enter the fast lane.
"With intelligent manufacturing as the core, the production capacity and quality of equipment can be brought to a higher level.
" The industry said.

　　In October 2020, the "digital factory" was officially launched at the pharmaceutical equipment factory of Xinhua Medical Pharmaceutical Technology Group .
It is reported that the plant is conducive to cost reduction, efficiency improvement and standardization implementation through information, digital, and intelligent means, helping to achieve customer-centric high-quality development.

Pharmaceutical equipment

　　Original title: In 2021, the pharmaceutical equipment industry will present 4 major trends

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.